Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Product Type Segment | Animal Glycated Albumin Assay, Human Glycated Albumin Assay |
| Application Segment | Research, Diagnostics |
| End User Segment | Hospital, Diagnostic Centers, Research Centers, Others |
|---|---|
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
AMS Biotechnology (Europe) Ltd. is providing life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. Products offered by the company are segmented into biorepository, molecular biology, antibodies, proteins & peptides, cells & cell culture, reagents & labware, kits & assay and others. Biorepository includes, DNA, RNA, Tissues, Biofluids and others.
Further, antibodies segment includes monoclonal, polyclonal and secondary antibodies. In addition, proteins & peptides includes recombinant proteins, overexpression lysates, mass spec standers, cell line lysates and others. Similarly, other products segments include different types of products.
December 2021
AMSBIO opened a new office in Alkmaar, Netherlands. The new AMSBIO Europe BV office is already providing EU customers rapid, easy access to the company’s extensive range of top-quality products and consumables.
Geno Technology Inc. is a manufacturer of G-Biosciences biotechnology and life science research products.
Products offered by the company are segmented into proteomics, DNA & RNA, Bioassays, science Edu and others. Proteomics includes detergents & accessories, lysis & extraction systems, antibody production & purification, labelling 7 conjugation, protein cross-linking & protein modification, protease & protease inhibitor systems, purification & chromatography, lysates & premise blots and others product categories.
Further, DNA & RNA segment includes genomic DNA purification, RNA isolation, plasmid purification & colony screening, PCR reagents and other product categories. Bioassays segment includes ELISA kits, enzyme substrates, antibiotics, beta-galactosidase, enzymes, cell health assays and others.
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Asahi Kasei Corporation | ••• | ••• | ••• | ••• |
| Diazyme Laboratories | ••• | ••• | ••• | ••• |
| LifeSpan BioSciences | ••• | ••• | ••• | ••• |
| Biomatik Corporation | ••• | ••• | ••• | ••• |
| Abbexa Ltd. | ••• | ••• | ••• | ••• |
| Geno Technology | ••• | ••• | ••• | ••• |
| DRG International | ••• | ••• | ••• | ••• |
| Inc | ••• | ••• | ••• | ••• |
| AMS Biotechnology (Europe) Limited | ••• | ••• | ••• | ••• |
| Abnova Corporation | ••• | ••• | ••• | ••• |
| Ethos Biosciences | ••• | ••• | ••• | ••• |
| Epinex Diagnostics Inc. | ••• | ••• | ••• | ••• |
| DxGen Corp | ••• | ••• | ••• | ••• |
| Others | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →As per Cognitive Market Research's latest published report, the Global Glycated Albumin market size will be $706.28 Million by 2030. The glycated Albumin Industry's Compound Annual Growth Rate will be 7.53% from 2023 to 2030.
The North America Glycated Albumin market size will be USD 126.64 Million by 2029.
The glycated albumin (GA) test represents short-term glycemia and is unaffected by circumstances that erroneously change A1C results. Glycated albumin has the most glycated fructosamine.
Glycated Albumin is a kind of glycosylated protein formed by a covalent bond between glucose and albumin. Glycated Albumin, like HbA1c, can be used to assess diabetics' long-term glucose management.
It has a shorter half-life than HbA1c and is likely to be more sensitive to variations in glucose concentrations in the near term. Hemoglobin variations influence some HbA1c assays. This interference does not affect glycated albumin.
It is assessed using a standardized enzymatic approach that is simple and quick to implement. These laboratory properties have assured that glycated albumin has been highlighted in research over the last decade as a marker of DM monitoring and screening, as well as a predictor of long-term disease outcomes.
Glycated albumin can be employed in both human and animal diagnostic and research experiments. It is mostly utilized by hospitals, diagnostic clinics, research facilities, and other organizations.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Glycated Albumin Market Analysis is witnessing significant growth in the near future. In 2023, the Animal Glycated Albumin Assay segment accounted for a notable share of the Global Glycated Albumin Market Analysis.Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Glycated Albumin Market Analysis is witnessing significant growth in the near future.
In 2023, the Animal Glycated Albumin Assay segment accounted for a notable share of the Global Glycated Albumin Market Analysis.
★ Reviews
Rate this report
| Product Type | Animal Glycated Albumin Assay, Human Glycated Albumin Assay |
| Application | Research, Diagnostics |
| End User | Hospital, Diagnostic Centers, Research Centers, Others |
| List of Competitors | Asahi Kasei Corporation, Diazyme Laboratories, LifeSpan BioSciences, Biomatik Corporation, Abbexa Ltd., Geno Technology, DRG International, Inc, AMS Biotechnology (Europe) Limited, Abnova Corporation, Ethos Biosciences, Epinex Diagnostics Inc., DxGen Corp, Others |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Glycated Albumin Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Glycated Albumin Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global glycated albumin market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.